Evidence map›Paper›PMID 24098145›Full record

ArticlePLoS genetics2013

The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.

Minh-Duy Phan, Kate M Peters, Sohinee Sarkar, Samuel W Lukowski, Luke P Allsopp, Danilo Gomes Moriel, Maud E S Achard, Makrina Totsika, Vikki M Marshall, Mathew Upton and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. NeuO-mediated O-acetylation of uropathogenicJournal of bacteriology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Alterations inFrontiers in cellular and infection microbiology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An ovine septic shock model of live bacterial infusion.Intensive care medicine experimental · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Minh-Duy PhanAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Kate M Peters
Sohinee Sarkar
Samuel W Lukowski
Luke P Allsopp
Danilo Gomes Moriel
Maud E S Achard
Makrina Totsika
Vikki M Marshall
Mathew Upton
Scott A Beatson
Mark A Schembri
University of Queensland · AUUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli ST131 is a globally disseminated, multidrug resistant clone responsible for a high proportion of urinary tract and bloodstream infections. The rapid emergence and successful spread of E. coli ST131 is strongly associated with antibiotic resistance; however, this phenotype alone is unlikely to explain its dominance amongst multidrug resistant uropathogens circulating worldwide in hospitals and the community. Thus, a greater understanding of the molecular mechanisms that underpin the fitness of E. coli ST131 is required. In this study, we employed hyper-saturated transposon mutagenesis in combination with multiplexed transposon directed insertion-site sequencing to define the essential genes required for in vitro growth and the serum resistome (i.e. genes required for resistance to human serum) of E. coli EC958, a representative of the predominant E. coli ST131 clonal lineage. We identified 315 essential genes in E. coli EC958, 231 (73%) of which were also essential in E. coli K-12. The serum resistome comprised 56 genes, the majority of which encode membrane proteins or factors involved in lipopolysaccharide (LPS) biosynthesis. Targeted mutagenesis confirmed a role in serum resistance for 46 (82%) of these genes. The murein lipoprotein Lpp, along with two lipid A-core biosynthesis enzymes WaaP and WaaG, were most strongly associated with serum resistance. While LPS was the main resistance mechanism defined for E. coli EC958 in serum, the enterobacterial common antigen and colanic acid also impacted on this phenotype. Our analysis also identified a novel function for two genes, hyxA and hyxR, as minor regulators of O-antigen chain length. This study offers novel insight into the genetic make-up of E. coli ST131, and provides a framework for future research on E. coli and other Gram-negative pathogens to define their essential gene repertoire and to dissect the molecular mechanisms that enable them to survive in the bloodstream and cause disease.

Indexed as

beta-LactamasesBloodDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialHumansMolecular EpidemiologyMutagenesisUrinary Tract InfectionsUropathogenic Escherichia coliVirulencebeta-Lactamases

Identifiers

PMID24098145
PMCPMC3789825
OpenAlexW1986815313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.